ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
GlucoTrack Inc

GlucoTrack Inc (GCTK)

0.0935
0.0023
(2.52%)
Cerrado 29 Enero 3:00PM
0.0953
0.0018
( 1.93% )
Pre Mercado: 3:16AM

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Estadísticas y detalles clave

Último Precio
0.0953
Postura de Compra
0.0952
Postura de Venta
0.0999
Volume Operado de la Acción
30,149
0.00 Rango del Día 0.00
0.0622 Rango de 52 semanas 4.95
Capitalización de Mercado [m]
Precio Anterior
0.0935
Precio de Apertura
-
Última hora de negociación
03:16:44
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
48,434,293
Acciones en circulación
5,772,026
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-0.07
Beneficio por acción (BPA)
-1.23
turnover
-
Beneficio neto
-7.1M

Acerca de GlucoTrack Inc

GlucoTrack Inc, former Integrity Applications, Inc. is a medical device company. The Company is focused on the design, development and commercialization of non-invasive glucose monitoring devices for use by persons suffering from diabetes. It has developed a non-invasive blood glucose monitor, the G... GlucoTrack Inc, former Integrity Applications, Inc. is a medical device company. The Company is focused on the design, development and commercialization of non-invasive glucose monitoring devices for use by persons suffering from diabetes. It has developed a non-invasive blood glucose monitor, the GlucoTrack Model DF-F glucose monitoring device, which is designed to help people with diabetes obtain blood glucose level readings without the pain, inconvenience, cost and difficulty of conventional (invasive) spot finger stick devices. The Company operates in Europe, and Asia and Pacific. The GlucoTrack model DF-F utilizes a combination of ultrasound, electromagnetic and thermal technologies to obtain blood glucose measurements in less than one minute through a small sensor that is clipped onto one's earlobe and connected to a small, handheld control and display unit, all without drawing blood. Mostrar más

Sector
Surgical,med Instr,apparatus
Industria
Surgical,med Instr,apparatus
Sede
Wilmington, Delaware, USA
Fundado
-
GlucoTrack Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker GCTK. The last closing price for GlucoTrack was US$0.09. Over the last year, GlucoTrack shares have traded in a share price range of US$ 0.0622 to US$ 4.95.

GlucoTrack currently has 5,772,026 shares in issue. The market capitalisation of GlucoTrack is US$539,684.43 . GlucoTrack has a price to earnings ratio (PE ratio) of -0.07.

GCTK Últimas noticias

Glucotrack Strengthens Leadership Team with Appointment of New Chief Financial Officer

RUTHERFORD, N.J., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and...

Glucotrack Announces ISO 13485:2016 Certification

RUTHERFORD, N.J., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and...

Glucotrack Strenghtens Leadership Team with Addition of Industry Veteran as Vice President of Regulatory Affairs

RUTHERFORD, N.J., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and...

Glucotrack to Present at TechBio Showcase™ 2025

RUTHERFORD, N.J., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.00111.167728237790.09420.11150.086307968980.09398772CS
4-0.2936-75.49498585750.38890.390.06221547062450.12086231CS
12-1.1547-92.3761.251.790.0622484342930.12335828CS
26-1.2797-93.06909090911.3753.130.0622211802480.1258229CS
52-0.9547-90.92380952381.054.950.0622107332590.13788597CS
156-15.7047-99.39683544315.821.20.062240031150.82641641CS
260-15.7047-99.39683544315.821.20.062240031150.82641641CS

GCTK - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de GlucoTrack?
El precio actual de las acciones de GlucoTrack es US$ 0.0953
¿Cuántas acciones de GlucoTrack están en circulación?
GlucoTrack tiene 5,772,026 acciones en circulación
¿Cuál es la capitalización de mercado de GlucoTrack?
La capitalización de mercado de GlucoTrack es USD 539.68k
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de GlucoTrack?
GlucoTrack ha negociado en un rango de US$ 0.0622 a US$ 4.95 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de GlucoTrack?
El ratio precio/beneficio de GlucoTrack es -0.07
¿Cuál es la moneda de reporte de GlucoTrack?
GlucoTrack presenta sus resultados financieros en USD
¿Cuál es el último beneficio anual de GlucoTrack?
El último beneficio anual de GlucoTrack es USD -7.1M
¿Cuál es la dirección registrada de GlucoTrack?
La dirección registrada de GlucoTrack es 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
¿Cuál es la dirección del sitio web de GlucoTrack?
La dirección del sitio web de GlucoTrack es www.integrity-app.com
¿En qué sector industrial opera GlucoTrack?
GlucoTrack opera en el sector SURGICAL,MED INSTR,APPARATUS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
ATHEAlterity Therapeutics Limited
US$ 6.15
(111.34%)
582.93k
CFSBCFSB Bancorp Inc
US$ 12.00
(57.27%)
6
NAOVNanoVibronix Inc
US$ 0.6025
(57.11%)
2.34M
GDEVGDEV Inc
US$ 24.99
(56.29%)
1
BANXArrowMark Financial Corporation
US$ 31.99
(50.19%)
1
CRGXCARGO Therapeutics Inc
US$ 3.20
(-75.74%)
98.58k
IZTCInvizyne Technologies Inc
US$ 8.00
(-49.72%)
114
NATRNatures Sunshine Products Inc
US$ 8.00
(-46.60%)
101
ECBKECB Bancorp Inc
US$ 8.01
(-41.49%)
1
FBLAFB Bancorp Inc
US$ 7.01
(-40.34%)
2
XFORX4 Pharmaceuticals Inc
US$ 1.01
(37.38%)
4.35M
MGOLMGO Global Inc
US$ 0.1239
(21.83%)
3.5M
NAOVNanoVibronix Inc
US$ 0.6025
(57.11%)
2.34M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 26.08
(5.46%)
1.08M
NVDANVIDIA Corporation
US$ 124.19
(0.40%)
615.04k

GCTK Discussion

Ver más
green maschine green maschine 12 horas hace
I exited A/H when it dropped. This has been vote approved for an r/s so I don't want to put it past the new CFO to effect it. It's a long ways from $1.
👍️0
infamous infamous 14 horas hace
2 large gaps to fill and good news coming out.nice recipe!
👍️0
infamous infamous 14 horas hace
i know i saw that. this IMO will go above .40 soon.
👍️0
green maschine green maschine 15 horas hace
Glucotrack Strengthens Leadership Team with Appointment of New Chief Financial Officer:
https://finance.yahoo.com/news/glucotrack-strengthens-leadership-team-appointment-140000358.html
👍️0
ErnieBilco ErnieBilco 1 día hace
The only eyes on this are those eyes that got caught on the last pump and dump attempt.

RS still approved and on the table - anyone who has followed this company knows its a loser, real companies don't run their ticker from dollars to under a dime with more debt than they can ever hope to pay down, hence the 150% increase in AS being approved also.
👍️0
infamous infamous 2 días hace
i can see this making a break to .40 to ..80 soon IMO. its getting eyes IMO.
👍️0
ErnieBilco ErnieBilco 1 semana hace
Rutrowwww where did all the pushers go? On to a fresher turd?
👍️0
leverage102 leverage102 1 semana hace
GCTK RSI Super Low 32 $$$. https://stockcharts.com/sc3/ui/?s=GCTK
👍️0
leverage102 leverage102 1 semana hace
Outstanding is low to begin with; hence increasing the shares 100 or 150 % is inline. Float would still be considered Low. Could be on the verge of Launching New Products; ; shares are being Absorbed.

GCTK $$$$
👍️ 1
leverage102 leverage102 1 semana hace
GCTK $$$. https://nakedshortreport.com/company/GCTK
👍️0
ErnieBilco ErnieBilco 1 semana hace
The OS is obviously much much larger that it was in November, the pumps just allow them to dump more and more shares Paulie thanks all those helping to dilute the crap out of this failure.
👍️0
Scotty9 Scotty9 1 semana hace
Thanks for the info
👍️0
green maschine green maschine 1 semana hace
Raising the A/S does not affect SP or O/S. It will be good to have more shares available to the flood of new investors when the device is approved. Did they notify you personally that they're doing an r/s? Voting on an r/s is common and doesn't mean it's going to happen.
👍️0
ErnieBilco ErnieBilco 1 semana hace
Scotty don't listen to pumpty dumpty there is in FACT a RS coming - the company is not in compliance with the $1 minimum and they are broke, like 6 times more debt than assets AND they are raising the AS 150%. Sound promising?
👍️0
ErnieBilco ErnieBilco 1 semana hace
Learn to read - I worked at a company that went thru the ISO bullsht.

Pump on
👍️0
Cornwhale Cornwhale 1 semana hace
Ok
👍️ 1
green maschine green maschine 1 semana hace
No. They just completed one last May.
👍️0
green maschine green maschine 1 semana hace
'Ai' response to question: Does ISO certification carry any weight?

"Absolutely, ISO certification can be quite significant. It demonstrates that a company adheres to international standards for quality, safety, efficiency, and more. This can enhance a company's reputation, increase customer trust, and open up new market opportunities. It also often leads to improved internal processes and operational efficiency. So, yes, ISO certification can carry a lot of weight in various industries."
👍️0
green maschine green maschine 1 semana hace
Yeah right, you worked at ISO certification...lol. What BS.
👍️0
Invest-in-America Invest-in-America 1 semana hace
GCTK: Their cute Blood test stuff now certified for Britain.
https://finance.yahoo.com/news/glucotrack-announces-iso-13485-2016-130100677.html
///////////////////////////////////////////////////////////////////////////////////////////
👍️0
ErnieBilco ErnieBilco 1 semana hace
ISO is as worthless as the "procedures" that are written on the paper. It's all BS - I worked at a ISO certified company and they never followed the rules they had set in their ISO manuals. Yes a RS will be coming and they are also raising the AS 150% - Paul is a conman with a PhD.
👍️0
tw0122 tw0122 1 semana hace
Flip some .09s  at .12 like it 
👍️0
Scotty9 Scotty9 1 semana hace
Is there a r/s split coming
👍️0
BankingBig BankingBig 2 semanas hace
This is going to have an epic run this upcoming week! Easy 10 bag
👍️0
ErnieBilco ErnieBilco 2 semanas hace
Garbage is more valuable than this turd run by losers with no business acumen at all. Hard to find a more poorly run company than this.

Pumpers arrive to move the needle just before the RS is due to hit after management sold out the AS.

THIS IS A PINKSHEETS OPERATION NOT A VALID NASDAQ LISTED FIRM.
👍️0
green maschine green maschine 2 semanas hace
It's about that time.
👍️ 1
Cornwhale Cornwhale 2 semanas hace
Got som. Burrrito money. Hungry af
😂 2
Cornwhale Cornwhale 2 semanas hace
Let’s Glucooo!!
👍️ 1
leverage102 leverage102 2 semanas hace
Now that I'm in; what does this company do ? 🤑
😂 1
tw0122 tw0122 2 semanas hace
 .10 Inverse head and shoulders breakout mode back to  20s soon
👍️ 2
Deeznuts Deeznuts 2 semanas hace
GARBAGE
👍 2
Deeznuts Deeznuts 2 semanas hace
Holding 5 days now, every day pumpers saying $1, but keeps dropping!
👍️ 1 🚀 2
Deeznuts Deeznuts 2 semanas hace
Man, what a load of garbage!
👍 1
green maschine green maschine 2 semanas hace
Picked up some .13s AH. Looks ready to bounce.
👍️ 1
glenn1919 glenn1919 2 semanas hace
GCTK........................https://stockcharts.com/h-sc/ui?s=GCTK&p=W&b=5&g=0&id=p86431144783
👍️0
Golden Cross Golden Cross 2 semanas hace
Glucotrack to Present at TechBio Showcase™ 2025

Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced that it is presenting at TechBio Showcase, part of Biotech Showcase™ 2025. Paul V. Goode, President and Chief Executive Officer, will give a corporate update on the Company’s Continuous Blood Glucose Monitor (CBGM).
Date: Tuesday, January 14
Time: 9:30am PT
Track: Yosemite C (Ballroom Level)

TechBio Showcase, as part of Biotech Showcase, is produced by Demy-Colton and EBD Group, and is an investor conference focused on driving advances in therapeutic development by providing a sophisticated networking platform for executives and investors that fosters broad geographical investment and partnership opportunities. The conference takes place each year during the course of one of the industry's largest gatherings and busiest weeks. Register now to meet one-to-one: biotechshowcase.com.

For more information about Glucotrack’s CBGM, visit glucotrack.com. Information on the Company’s website does not constitute a part of and is not incorporated by reference into this press release.
👍️0
tw0122 tw0122 2 semanas hace
.13s looked ok .17s better + 50% into Tuesday diabetes conference 
👍 1
Acme Investments Acme Investments 3 semanas hace
Everybody is loading!! Lol!! Tap me when you have profits!! I'll be watching!!
👍️0
Double DD Double DD 3 semanas hace
Loading more here!! 
👍️0
Acme Investments Acme Investments 3 semanas hace
At any time it could have a dead cat bounce but it's too many potential plays out here to leave any money sitting here!!
👍️0
Double DD Double DD 3 semanas hace
That's a helluva lot of volume for a 9 million float stock. Even if they max outstanding out that's only 16 mill. Geez flipped the outstanding over 10x today!! Hmmmmm
👍️0
Acme Investments Acme Investments 2 meses hace
What happened here??
👍️0
ErnieBilco ErnieBilco 2 meses hace
And there it is These con artists diluted the crap out of the AS that this week they now want to pull a RS so they can sell it down again.

Very very poorly run operation Maybe consider a real CEO and a BOD with backbones and business skills.
👍️0
ErnieBilco ErnieBilco 2 meses hace
Fluffer out so they must be getting ready for another offering OR the RS so they can fleece a new group of shareholders at a higher price.

This has really turned out to be a sad sad operation.
👍️0
ErnieBilco ErnieBilco 2 meses hace
And there it is, these goofmos diluted the crap out of this so now they want to steal the shares back with a Reverse Split.
Can they get any more pinkish than that. But Nasdaq loves it to keep the fees coming in for listing on the turd board.
👍️0
ErnieBilco ErnieBilco 2 meses hace
Looks like this turd is entering a death spiral they will never recover from. What a shame what crap management can do to a company.
👍️0
Darrdarr Darrdarr 2 meses hace
oh yes bot another 10k shares @ .265 put my avg .31 she allmost ready... the pop will start monday if not later this afternoon...
👍️0
Acme Investments Acme Investments 2 meses hace
You hanging in there??
👍️0
Acme Investments Acme Investments 3 meses hace
I just looked at it!! Might be a good idea??
👍️0
Darrdarr Darrdarr 3 meses hace
Not me bought 10k shares at .345 ready for a good dead cat bounce...
👍️0

Su Consulta Reciente

Delayed Upgrade Clock